share_log

公告精选 | 药明康德年度归母净利同比预增近70%;永达汽车年度净利同比预增不少于50%

Selected Announcements | Yao Ming Kangde's annual net profit is expected to increase by nearly 70% year-on-year; Yongda Automobile's annual net profit is expected to increase by no less than 50% year-on-year

富途資訊 ·  Jan 19, 2022 08:21

Selection of blockbuster announcements

1、$Wuxi Apptec (02359.HK) $The net profit in 2021 is expected to increase by 68% and 70%.

Wuxi Apptec sends Yingxi, the annual operating income in 2021 is expected to be between 228.19 and 22.902 billion yuan (the same below), an annual increase of 38 percent. The net profit attributable to shareholders ranges from 49.73 to 5.032 billion yuan, an increase of 68 percent. After deducting non-recurrent profits and losses, the estimated net profit ranges from 40.07 to 4.055 billion yuan, an increase of 68 percent.

2、$Yongda Motor (03669.HK) $Expected annual net profit growth of not less than 50% compared with the same period last year

According to the group's preliminary assessment of the unaudited consolidated management accounts for the year ended 31 December 2021 and the information currently available to the board of directors, it is expected that the consolidated net profit attributable to shareholders of the company for the year ended 31 December 2020 will increase by not less than 50% compared with the year ended 31 December 2020. The increase in consolidated net profit attributable to shareholders of the above companies compared with the same period in 2020 is mainly attributable to (I) higher new car sales and improved gross profit margin; (ii) relatively rapid growth in after-sales service revenue; and (iii) rapid development of used car business.

3、$China Railway Construction Corporation (01186.HK) $The total value of newly signed contracts in 2021 is 2.82 trillion yuan, an increase of 10.39% over the same period last year.

China Railway Construction Corporation announced that from January to December 2021, the company's newly signed contracts totaled 2.8196516 trillion yuan, an increase of 10.39 percent over the same period last year.

4、$Kingboard Laminates (01888.HK) $Annual net profit is expected to increase by 132% to 150%

According to the announcement of Jiantao laminate, the group expects to record a net profit of about HK $6.5 billion to HK $7 billion for the year ended December 31, 2021, an increase of about 132% to 150% over the same period in 2020. According to the announcement, the net profit of Kingboard laminates increased significantly in that year, mainly due to strong market demand, and the sales volume and unit price of the Group's products increased significantly compared with the same period in 2020. The supply of upstream raw materials including copper foil, glass cloth and epoxy resin is very tight, and the unit price of products continues to run at a high level.

5、$PRADA S.p.A. (01913.HK) $The group's total income in 2021 increased by 41% year on year and 8% to 3.364 billion euros compared with 2019.

PRADA S.p.A. announced that for the whole of 2021, the group's total revenue was 3.364 billion euros, an increase of 41 per cent over 2020 and 8 per cent over 2019 at a fixed exchange rate, driven by the outstanding performance of retail channels. In the second half of the year, sales of direct stores (including e-commerce) increased by 27% over 2020 and 21% over 2019 at fixed exchange rates.

6、$Golly Pharmaceuticals-B (01672.HK) $Sign the purchase agreement of ritonavir tablets with Laos Phokam Pharmaceutical Import-Export Co., Ltd

Goliath Pharmaceutical-B announced that Laos Phokam Pharmaceutical Import-Export Co., Ltd (buyer) and the company's wholly-owned subsidiary Geli Pharmaceutical (Zhejiang) Co., Ltd. (seller) signed an agreement for the purchase of Litonavir tablets. Ritonavir oral tablets are pharmacokinetic enhancers for a variety of oral antiviral drugs for viral proteases.

  • AHInteraction

Haier Smart Home (06690): complete the registration of granting 4.5252 million A-share stock options

  • Important matters

Shanghai Fosun Pharmaceutical (02196): Fuhong Hanlin was approved for drug clinical trial

Heyu-B (02256): global cooperation with Eli Lilly and Co to discover and develop new small molecular drugs

Xianruida Medical-B (06669): the State Drug Administration of China accepts the application for listing license for arteriovenous introduction of DCB products.

Kangji Medical (09997): plan to invest 351 million yuan in Hangzhou Weijing Medical Robot

Cornerstone Pharmaceutical-B (02616): subjects enrolled in two major phase III registered clinical trials with sulgarizumab

Cornerstone Pharmaceutical-B (02616): GEMSTONE-302 study of sugarizumab in the first-line treatment of metastatic NSCLC reaches the end point of overall survival.

Hansoh Pharmaceutical Group (03692): "HS-10382 tablet" is intended to be used in the treatment of chronic myeloid leukemia

Goliath Pharmaceuticals-B (01672): signing Litonavir tablet purchase Agreement with Laos Phokam Pharmaceutical Import-Export Co., Ltd

Fu Hong Hanlin (02696): HLX208 (BRAF V600E inhibitor): application for phase 1b/2 clinical trial of single or combined therapy for advanced solid tumors with positive BRAF V600E or BRAF V600 mutations approved

Man Wah (01999): plan to purchase industrial land in Monterey, Mexico

IGG (00799): award a construction contract of about $422 million to the first construction of the eighth Bureau of China Construction

Xintian Green Energy (00956): it is proposed to contribute 179 million yuan to join the joint venture to invest in new energy industry.

Yamei Energy (02686): to establish a joint venture with New Natural Gas (603393.SH) to engage in R & D business such as geological reserves technology, drilling technology, etc.

  • Financial report data

China Xinlianxin Chemical Fertilizer (01866): net profit is expected to increase by no less than 200% year on year in 2021.

Jiantao laminate (01888): net profit is expected to increase by about 132% per cent over the same period last year to about HK $6.5 billion-HK $7 billion.

Kingboard Holdings (00148): net profit in 2021 is expected to increase by about 113% to 134% to HK $10 billion to HK $11 billion

China Hanwang (03788): expected annual profit of 650 million yuan or 72% year-on-year increase

Wuxi Apptec (02359): it is estimated that the net profit of returning home in 2021 will reach 4.973 billion to 5.032 billion yuan, an increase of 68% to 70% over the same period last year.

Yongda Automobile (03669): it is expected that the consolidated net profit attributable to shareholders will increase by not less than 50% year-on-year.

PRADA S.p.A. (01913): total income of the Group in 2021 increased by 41% compared with the same period last year and by 8% over 2019 to 3.364 billion euros

China Everbright Bank (06818): the net profit of returning home in 2021 increased by 14.73% to 43.407 billion yuan.

Yashili International (01230): annual profit increases by 10% to 20%

China Railway Construction Corporation (01186): the total value of newly signed contracts in 2021 totaled 2.82 trillion yuan, up 10.39% from the same period last year.

Value Management Group (00806): total assets under management at the end of December were approximately $10 billion

Tianhong Textile (02678): the net profit after tax in the second half of 2021 is expected to be similar to that in the first half of 2021.

361degrees (01361): retail sales of main brand products achieved high double-digit growth in the fourth quarter compared with the same period last year.

  • Tender offer

Bandung Holdings Group (00030): 3.102 billion offer shares have been effectively accepted

  • Repurchase cancellation

Tencent (00700): repurchased 440000 shares at a cost of about HK $202 million

Tianlun Gas (01600): repurchased 1.4 million shares at a cost of about HK $12.4451 million on January 18

China Vanguard Pharmaceutical (01345): repurchase 2.6 million shares with HK $5.1538 million on January 18

Country Garden Services Holdings (06098): HK $4.91 million buyback 125000 shares on January 18th

CNPC (00603): HK $4.68 million buyback 10 million shares on January 18

HSBC Holdings PLC (00005): buy back 756900 shares on January 17th

HSBC Holdings PLC (00005): buy back 2.9655 million shares on January 18th

CK Hutchison (00001): write off 100000 repurchased shares on January 18

  • Additional placement

Zall Zhaopin (02098): to raise HK 300 million by issuing 600 million shares at a premium of about 13.64% to the controlling shareholder

Jiahe Bio-B (06998): issued 1.449 million shares due to the exercise of share options by directors on January 18

Kangsheng Global (09960): a total of 996000 shares were issued due to the exercise of options on January 18.

Xingfa Aluminum (00098): issuing 81000 additional shares under the share option Plan

Wuxi Apptec (02359): issued 71100 shares due to conversion of convertible bonds

Murong Home (01575): proposed premium of about 43.44% to place a maximum of 200 million shares with a net chip of about HK $34.65 million

  • Stock option

Hengan Internationgal Group (01044): 44.747 million share options granted

JS Global Lifestyle Company Limited (01691): the trustee has purchased 2.757 million shares in respect of the restricted share unit.

  • Dividend dividend

China Jinmao (00817): plans to pay a special dividend in the form of in-kind distribution of Jinmao service shares

  • Asset merger and acquisition

Lu Jin (01098): plans to acquire Hongze's real estate rights and interests with 542 million yuan

  • Asset sale

Senmei Holdings (00756): affiliated Senmei (Fujian): the price of Quanzhou property for food sale is 38.8 million yuan

Bank of China Leasing (01606): it is proposed to transfer fixed assets such as transportation hub operation equipment in Zhejiang Province from 1.002 billion yuan to Beiyin Financial Leasing.

Shanghai Electric (02727): about 608 million yuan transfer Ningxia Ningbo fund share

  • Bond bill

Agile Group (03383): cumulative repurchase of 2019 notes with a total principal of $23 million

China Jinmao (00817): Fang Xing Guangyao has completed the redemption and write-off of capital securities with a principal of US $500m.

  • Guaranteed loan

Chunli Medical (01858): to apply for a comprehensive credit line of no more than 500 million yuan

Cosco Haifa (02866): intends to provide guarantee for Tianjin lease and Oriental Fuli to borrow a total of not more than 526 million yuan

  • Change of equity

Greentown Management Holdings (09979): Li Jun, executive director, increased his stake in 645000 shares.

  • Personnel change

AVIC (02357): appoint Zhang Minsheng as Chairman of the Board

China Tower Corporation (00788): Zhang Zhiyong was appointed Chairman of the Board.

Edit / irisz

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment